BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mohyeldin M, Shrivastava S, Allu SVV. Ibrutinib and atrial fibrillation: An in-depth review of clinical implications and management strategies. World J Cardiol 2024; 16(5): 269-273 [PMID: 38817647 DOI: 10.4330/wjc.v16.i5.269]
URL: https://www.wjgnet.com/1949-8462/full/v16/i5/269.htm
Number Citing Articles
1
Ibraheem Othman, Seyedeh Zahra (Mona) Moossavi, Samaneh Bayati, Yi Sin Chang, Shubrandu Sanjoy, Karolina Grzyb, Eric Sy, Kayla Cropper, Sandy Kassir, Waleed Sabry. Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia: Adverse Event Incidence, Management, and Outcomes in a Canadian Real-World SettingCurrent Oncology 2025; 32(6): 296 doi: 10.3390/curroncol32060296
2
Drew A. Wells, Zachery Halford, Kori Holman, Dennis Marjoncu. Cancer Therapy‐Induced Cardiotoxicity: A Narrative ReviewPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2026; 46(2) doi: 10.1002/phar.70110